Drug Trial Radar · NCT06007066
HSK16149 for Perioperative Analgesia in Orthopedic Surgery
Last checked: Nov 20, 2026Latest source record: Aug 23, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
235
Actual
Start
Mar 8, 2023
Primary completion
Jun 12, 2023
Study completion Jul 5, 2023
Sponsor
- Lead sponsor
- Haisco Pharmaceutical Group Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Aug 23, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will compare the effect and safety of HSK16149 with placebo on perioperative analgesia in orthopedic surgery, and explore the dosage of HSK16149 capsules for orthopedic analgesia during perioperative period.
Conditions
- Post-operative Pain
Interventions
HSK16149 capsuleDrug
Subjects will be given 40mg or 60mg of HSK16149 orally.
PlaceboDrug
Subjects will be given HSK16149 placebo orally.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Morphine ConsumptionTime frame: Participants received PCA pump, an average of 24 hours after surgery
Locations
21 sites in 1 country. Site status is shown where the registry gives one.
Sino-Japanese Friendship Hospital
Beijing, China
Dongguan People's Hospital
Dongguan, Guangdong, China
Foshan Fuxing Chancheng Hospital
Foshan, Guangdong, China
The First Affiliated Hospital of Jinan University
Guangzhou, Guangdong, China
Affiliated Hospital of Guizhou Medical University
Guiyang, Guizhou, China
Beijing Jishuitan Hospital Guizhou Hospital
Guiyang, Guizhou, China
Zunyi University Affiliated Hospital
Zunyi, Guizhou, China
Henan Provincial People's Hospital
Zhengzhou, Henan, China
People's Hospital of Wuhan University
Wuhan, Hubei, China
Wuhan Central Hospital
Wuhan, Hubei, China
Xiangya Third Hospital of Central South University
Changsha, Hunan, China
The First Affiliated Hospital of South China University
Hengyang, Hunan, China
Lianyungang First People's Hospital
Lianyungang, Jiangsu, China
Nanjing First Hospital
Nanjing, Jiangsu, China
Chengdu Second People's Hospital
Chengdu, Sichuan, China
Chengdu Third People's Hospital
Chengdu, Sichuan, China
Sichuan Provincial People's Hospital
Chengdu, Sichuan, China
Guangyuan First People's Hospital
Guangyuan, Sichuan, China
Mianyang Central Hospital
Mianyang, Sichuan, China
Yibin Second People's Hospital
Yibin, Sichuan, China
The First People's Hospital of Yunnan Province
Kunming, Yunnan, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.